$100,000 DEDICATED FROM SHARJAH TO THE UNSUNG HEROES OF REFUGEES

Award launched by Her Highness celebrates values of perseverance and conviction in the face of adversity

SHARJAH, United Arab Emirates, Jan 5 (Bernama-BUSINESS WIRE) -- In a first-of-its-kind effort to recognise people's outstanding efforts to the forcibly displaced people in Asia, the Middle East and North Africa (MENA), the 'Sharjah International Award ‎for Refugee Advocacy & Support', a $100,000 humanitarian award, was launched by The Ruling family of Sharjah, the third largest emirate in the United Arab Emirates (UAE).

Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of His Highness the Ruler of Sharjah, United Nations High Commissioner for Refugees' (UNHCR) Eminent Advocate for Refugee Children and Chairperson of The Big Heart Foundation (TBHF), launched the award as a tribute to those who have worked relentlessly to improve the lives of millions of refugees and displaced families.

http://mrem.bernama.com/viewsm.php?idm=28226

RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®

TEL-AVIV, Israel, Jan. 04, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced the signing of an exclusive co-promotion agreement with a subsidiary² of Concordia International Corp. (NASDAQ:CXRX) (TSX:CXR) (“Concordia”), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, granting RedHill certain U.S. promotion rights for Donnatal^®, a prescription oral drug used with other drugs in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis (inflammation of the small bowel)³.

Under the terms of the agreement, RedHill will be responsible for certain promotional activities related to Donnatal^®. Concordia will continue to be responsible for the manufacturing and supply of Donnatal^® in all territories. Donnatal^® accounted for 7.7% of Concordia’s consolidated revenues in the first half of 2016⁴. RedHill and Concordia will share the revenues generated from the promotion of Donnatal^® by RedHill based on an agreed upon split between them. The initial term of the co-promotion agreement with Concordia is for three years. RedHill expects to initiate gradual promotion of Donnatal^® in the coming months.

SOURCE : RedHill Biopharma Ltd

COLLIERS INTERNATIONAL COMPLETES MERGER

Integrates operations in Northern California and Nevada

TORONTO, Jan 4 (Bernama-GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI) (TSX:CIGI) today announced the completion of the previously announced merger with affiliate Colliers Parrish International Inc. (“CPI”).

With this move, Colliers International significantly increases its scale and coverage in Northern California and Nevada with additional offices in San Jose, Oakland, Stockton, Pleasanton, Redwood City, Fairfield, Mountain View, Gilroy and Walnut Creek, California, as well as Las Vegas and Reno, Nevada. The acquisition adds more than 400 professionals providing a comprehensive suite of services including investment sales, lease brokerage, capital markets, valuation and advisory and property management to local, regional, national and international clients. 

http://mrem.bernama.com/viewsm.php?idm=28223

NASDAQ HOLDS FOURTH QUARTER 2016 INVESTOR CONFERENCE CALL

NEW YORK, Jan 5 (Bernama-GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) has scheduled its Fourth Quarter 2016 results announcement.

Who:		Nasdaq’s CEO, CFO, and additional members of its management team
What:		Review Nasdaq’s Fourth Quarter 2016 Financial Results
When:		Tuesday, January 31, 2017
		Results Call: 8:00 a.m. Eastern Time.

http://mrem.bernama.com/viewsm.php?idm=28229

RedHill Biopharma Announces Exercise of Underwriters’ Option

TEL-AVIV, Israel, Jan. 04, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that the underwriters of its previously announced underwritten public offering of 2,250,000 American Depository Shares (“ADSs”), each representing 10 of its ordinary shares, and warrants to purchase 1,125,000 ADSs, have partially exercised their option and purchased 133,104 ADSs.

Source : RedHill Biopharma Ltd.

KAMIN LLC ANNOUNCES PRICE INCREASE FOR INDUSTRIAL HYDROUS KAOLIN CLAYS

MACON, Ga., Jan 3 (Bernama-GLOBE NEWSWIRE) -- KaMin LLC announced today that it will increase prices for hydrous kaolin clay products for the global industrial market 6-8% effective January 1, 2017, or as contracts allow.

http://mrem.bernama.com/viewsm.php?idm=28219

THE PRIVCO ASIA 50: RANKING ASIA'S LARGEST PRIVATE COMPANIES

NEW YORK, Dec 30 (Bernama-GLOBE NEWSWIRE) -- PrivCo has just released The PrivCo Asia 50: Ranking the Largest Private Companies in Asia by Revenue Report.

PrivCo screened through its proprietary Private Company Financial Database with information on over 900,000 private companies to rank the PrivCo Asia 50, the definitive ranking of the top 50 privately-held companies in Asia based on 2015 revenue. PrivCo has provided its Exclusive Top 5 Rankings below, with Huawei Investment & Holding Co., Ltd taking the top spot ranking as the #1 Largest Private Company in the PrivCo Asia 50. Ranked just behind it were Suning Holdings Group Co., Ltd (#2) & Shandong Weiqiao Pioneering Group (#3).

http://mrem.bernama.com/viewsm.php?idm=28211